Context
The first gene editing technology securing approval for the treatment of sickle cell anemia and beta-thalassemia utilise the Nobel-winning CRISPR/Cas 9 genome. However, the success of this technology hinges on a sufficient commitment to integrating ethics into its application.
The approved gene therapies
What is Sickle cell Anemia?
|
What is CRISPR?
How CRISPR works?
The CRISPR-Cas9 system consists of two key molecules that introduce a change (mutation) into the DNA. These are:
What are the issues?
What are the ethical concerns in CRISPR applications?
Regulatory Framework in India
More Articles
Verifying, please be patient.